NASDAQ:AMPH   Amphastar Pharmaceuticals, Inc.
After a deep pullback in August and September, Amphastar is coming back in a big way. Following its early-November earnings report, the stock is up more than 20% in the last few weeks. It has reclaimed all its moving averages and is now consolidation with a pivot at $58.

Volume has dried up nicely during this consolidation which is typically a sign the stock is becoming harder to buy and getting concentrated into strong institutional hands.

One might consider buying on a high-volume move above $58.

כתב ויתור

המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.